![5-(6-(3-Methoxyoxetan-3-yl)-4-Morpholinothieno[3,2-d]pyriMidin-2-yl)pyriMidin-2-aMine](https://static.cymitquimica.com/cas-image/549834-5-6-3-methoxyoxetan-3-yl-4-morpholinothieno-32-d-pyrimidin-2-yl-pyrimidin-2-amine.png)
CAS: 1394076-92-6 - 5-(6-(3-Methoxyoxetan-3-yl)-4-Morpholinothieno[3,2-d]pyriMidin-2-yl)pyriMidin-2-aMine
![5-(6-(3-Methoxyoxetan-3-yl)-4-Morpholinothieno[3,2-d]pyriMidin-2-yl)pyriMidin-2-aMine](https://static.cymitquimica.com/products/IN/thumb/DA009CI2.jpg)
5-(6-(3-Methoxyoxetan-3-yl)-4-Morpholinothieno[3,2-d]pyriMidin-2-yl)pyriMidin-2-aMine
CAS:1394076-92-6
Formula:
C19H22N6O3S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
414.4814
Ref: IN-DA009CI2
| 5mg | 138.00 € | ||
| 10mg | 151.00 € | ||
| 50mg | 178.00 € | ||
| 100mg | 299.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
GNE-317
CAS:1394076-92-6
GNE-317, a PI3K/mTOR inhibitor, can pass through the blood-brain barrier (BBB).
Formula:
C19H22N6O3S
Purity:
99.08% - 99.42%
Color and Shape:
Solid
Molecular weight:
414.48
Ref: TM-T6845
| 1mg | 39.00 € | ||
| 2mg | 51.00 € | ||
| 5mg | 82.00 € | ||
| 10mg | 118.00 € | ||
| 25mg | 207.00 € | ||
| 50mg | 342.00 € | ||
| 100mg | 426.00 € | ||
| 200mg | 623.00 € | ||
| 1mL*10mM (DMSO) | 92.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
GNE-317
CAS:1394076-92-6
GNE-317 is a cancer therapeutic that inhibits the activity of CDK4/6 and is currently in …
Formula:
C19H22N6O3S
Purity:
Min. 95%
Molecular weight:
414.48 g/mol
Ref: 3D-UFC07692
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025
